2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$13.13+$0.07 (+0.57%)
Price as of Oct 22, 2026 7:30 PM EDT- $447.9MMarket Cap
- 20.39%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$13.13+$0.07 (+0.57%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.05 | ||
Change | -$0.46 (-3.40%) | ||
Open | $13.51 | ||
High | $13.69 | ||
Low | $13.03 | ||
Previous Close | $13.51 | ||
Volume | 64,250 | ||
30-Day Average Volume | 122,892 | ||
1-Week Change | 3.90% | ||
1-Month Change | -10.25% | ||
1-Year Change | 20.39% | ||
3-Year Change | 89.68% | ||
5-Year Change | -15.31% | ||
Fundamentals | |||
Shares Outstanding | 34.3M | ||
Total Assets | $97.0M | ||
Market Cap | $447.9M | ||
Enterprise Value | $494.4M | ||
Period: QTR TTM FY | |||
Revenue | $22.8M | ||
Net Income | -$6.2M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -107 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 38 | ||
P/E | -73 | ||
PEG | -7 | ||
Price/Free Cash Flow | -111 | ||
Price/Operating Cash Flow | -115 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue